EphA2, a member of the tyrosine kinase family enriched in the PI3K/AKT pathway 27, has been shown to play a pivotal role in maintaining tumor cell stemness or promoting tumor growth through unconventional pathways 24-26, 28-31. The gene discussed is AKT1; the disease is neoplasm.